← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$16K

Shares

1,634

Price

$10

Filed

Feb 26

Insider

Name

O'Byrne Jason

Title

EVP & Chief Financial Officer

CIK

0001871145

Roles

Officer

Transaction Details

Transaction Date

2026-02-24

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

162,615

Footnotes

Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0001628280-26-012395

Form Type

4

Issuer CIK

0001706431

O'Byrne Jason's History

Date Ticker Type Value
2026-02-24 VIR $16K
2026-02-23 VIR $16K
2026-02-22 VIR A $0
2026-02-22 VIR A $0
2025-11-17 VIR $38K

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $992K 2026-04-01
De Backer Marianne
Chief Executive Officer
$283K 2026-02-24
De Backer Marianne
President and CEO
$664K 2026-04-06
Eisner Mark
EVP and Chief Medical Officer
$50K 2026-02-25
O'Byrne Jason
EVP & Chief Financial Officer
$16K 2026-02-23
de Verneuil Vanina
EVP, General Counsel, Corp Sec
$197K 2026-02-25
Sabatini Brent
SVP, Chief Accounting Officer
$110K 2026-03-23